Tubach F - Search Results

1

Feeling good rather than feeling better matters more to patients.

Tubach F, Dougados M, Falissard B, Baron G, Logeart I, Ravaud P. Tubach F, et al. Arthritis Rheum. 2006 Aug 15;55(4):526-30. doi: 10.1002/art.22110. Arthritis Rheum. 2006. PMID: 16874795 Free article. Clinical Trial.

2

Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis.

Boutron I, Tubach F, Giraudeau B, Ravaud P. Boutron I, et al. Among authors: tubach f. JAMA. 2003 Aug 27;290(8):1062-70. doi: 10.1001/jama.290.8.1062. JAMA. 2003. PMID: 12941679

3

Natural history and prognostic indicators of sciatica.

Tubach F, Beauté J, Leclerc A. Tubach F, et al. J Clin Epidemiol. 2004 Feb;57(2):174-9. doi: 10.1016/S0895-4356(03)00257-9. J Clin Epidemiol. 2004. PMID: 15125627

4

Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state.

Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M. Tubach F, et al. Ann Rheum Dis. 2005 Jan;64(1):34-7. doi: 10.1136/ard.2004.023028. Epub 2004 May 6. Ann Rheum Dis. 2005. PMID: 15130902 Free PMC article.

5

Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement.

Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M. Tubach F, et al. Ann Rheum Dis. 2005 Jan;64(1):29-33. doi: 10.1136/ard.2004.022905. Epub 2004 Jun 18. Ann Rheum Dis. 2005. PMID: 15208174 Free PMC article.

6

Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.

Boutron I, Tubach F, Giraudeau B, Ravaud P. Boutron I, et al. Among authors: tubach f. J Clin Epidemiol. 2004 Jun;57(6):543-50. doi: 10.1016/j.jclinepi.2003.12.010. J Clin Epidemiol. 2004. PMID: 15246122

7

Using patients' and rheumatologists' opinions to specify a short form of the WOMAC function subscale.

Tubach F, Baron G, Falissard B, Logeart I, Dougados M, Bellamy N, Ravaud P. Tubach F, et al. Ann Rheum Dis. 2005 Jan;64(1):75-9. doi: 10.1136/ard.2003.019539. Ann Rheum Dis. 2005. PMID: 15608303 Free PMC article.

8

Predictive factors of total hip replacement due to primary osteoarthritis: a prospective 2 year study of 505 patients.

Gossec L, Tubach F, Baron G, Ravaud P, Logeart I, Dougados M. Gossec L, et al. Among authors: tubach f. Ann Rheum Dis. 2005 Jul;64(7):1028-32. doi: 10.1136/ard.2004.029546. Epub 2005 Jan 7. Ann Rheum Dis. 2005. PMID: 15640268 Free PMC article.

9

Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.

Tubach F, Wells GA, Ravaud P, Dougados M. Tubach F, et al. J Rheumatol. 2005 Oct;32(10):2025-9. J Rheumatol. 2005. PMID: 16206363 Review.

10

Intraarticular glucocorticoid injections in rapidly destructive hip osteoarthritis.

Villoutreix C, Pham T, Tubach F, Dougados M, Ayral X. Villoutreix C, et al. Among authors: tubach f. Joint Bone Spine. 2006 Jan;73(1):66-71. doi: 10.1016/j.jbspin.2005.06.002. Epub 2005 Sep 22. Joint Bone Spine. 2006. PMID: 16256393

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results